A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the anti-tumor activity of BGB-A445 plus
investigational agents in participants with non-small cell lung cancer (NSCLC)